Basket | Login | Register

 
 
 
 

MK-4305-061 study (coming soon)

Clinical Trials Watch

Scientific title

Safety and Efficacy of Suvorexant (MK-4305) for the Treatment of Insomnia in Participants With Alzheimer's Disease

Study sponsor

Merck

Disease

Insomnia in Alzheimer’s disease

Name of drug

Suvorexant (MK-4305)

Link to full text

https://clinicaltrials.gov/ct2/show/NCT02750306

Please note that an accessible easy read version of this study is not yet available. The pharmaceutical company running this trial and a member of the European Working Group of People with Dementia are currently reviewing this document.

 

 
 

Last Updated: Wednesday 30 August 2017

 

 
 

Options